Oxford Industries (OXM) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Oxford Industries (OXM) reported Q1 revenue of $392.86 million, a 1.3% year-over-year decline but a +1.98% surprise over Zacks Consensus Estimate; EPS was $1.82, down from $2.66 YoY and in line with estimates. Key brand performances include Lilly Pulitzer with a +12% sales increase, while Tommy Bahama sales decreased by -4.2% and Johnny Was sales declined -15% year-over-year; OXM stock has underperformed the S&P 500 over the past month.

Analysis

Oxford Industries (OXM) reported Q1 revenue of $392.86 million, a 1.3% year-over-year decline, yet this figure surpassed the Zacks Consensus Estimate of $385.23 million by 1.98%. However, earnings per share (EPS) for the quarter were $1.82, a significant decrease from $2.66 in the prior year, although precisely meeting the consensus EPS estimate. A deeper look into brand performance reveals a mixed landscape: Net Sales for Lilly Pulitzer grew a robust 12% year-over-year to $99 million, exceeding the $91.10 million analyst estimate. Emerging Brands also showed positive momentum, with sales increasing 3.6% year-over-year to $34.20 million, slightly above the $33.70 million estimate. Conversely, Tommy Bahama, the largest brand by sales, experienced a 4.2% year-over-year decline to $216.20 million, albeit marginally beating the $214.30 million estimate. The Johnny Was brand faced considerable headwinds, with sales plummeting 15% year-over-year to $43.50 million, falling short of the $46.10 million estimate. Reflecting these mixed results and broader market conditions, OXM shares have underperformed, returning -6.4% over the past month compared to the S&P 500 composite's +6.9% gain. The stock currently holds a Zacks Rank #3 (Hold), suggesting expectations of in-line market performance in the near term.

Key Decisions for Investors

• Investors should weigh the positive revenue surprise and strong performance of the Lilly Pulitzer brand against the significant year-over-year EPS decline and concerning sales contraction in the Tommy Bahama and particularly the Johnny Was segments.
• Monitor future earnings reports for signs of stabilization or turnaround in the underperforming Johnny Was and Tommy Bahama brands, as their recovery is crucial for overall earnings improvement.
• Given the recent stock underperformance and the neutral Zacks Rank, a cautious stance may be warranted, pending clearer indications of sustained growth across the broader brand portfolio and an improvement in profitability.